Literature DB >> 10643890

Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease.

L Lilius1, S Froelich Fabre, H Basun, C Forsell, K Axelman, K Mattila, A Andreadis, M Viitanen, B Winblad, L Fratiglioni, L Lannfelt.   

Abstract

In an effort to analyze the genetic role of tau in Alzheimer's disease (AD), 17 polymorphisms were identified. Eleven of these polymorphisms were in complete linkage disequilibrium and segregated as two haplotypes, A and B. The A and B haplotypes were investigated in 269 AD cases and 238 controls from two different sources, a clinic-based group (mean age of onset 65+/-9 years), and a population-based group (mean age of onset 80+/-5 years). A synergistic effect between the common tau genotype AA and apolipoprotein E (APOE epsilon4) was found in the clinic-based AD group. Our study suggests that the common tau genotype AA may interact with APOE epsilon4 in increasing the risk of AD in a subgroup of the AD population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10643890     DOI: 10.1016/s0304-3940(99)00833-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.

Authors:  Xiaoyun Guo; Wenying Qiu; Rolando Garcia-Milian; Xiandong Lin; Yong Zhang; Yuping Cao; Yunlong Tan; Zhiren Wang; Jing Shi; Jijun Wang; Dengtang Liu; Lisheng Song; Yifeng Xu; Xiaoping Wang; Na Liu; Tao Sun; Jianming Zheng; Justine Luo; Huihao Zhang; Jianying Xu; Longli Kang; Chao Ma; Kesheng Wang; Xingguang Luo
Journal:  J Neural Transm (Vienna)       Date:  2017-08-02       Impact factor: 3.575

2.  Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer's disease in a sample of Colombian patients.

Authors:  D A Forero; G Arboleda; J J Yunis; R Pardo; H Arboleda
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

3.  A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease.

Authors:  Chris Conrad; Cintia Vianna; Melissa Freeman; Peter Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies.

Authors:  Prudence M Stanford; William S Brooks; Erdahl T Teber; Marianne Hallupp; Catriona McLean; Glenda M Halliday; Ralph N Martins; John B J Kwok; Peter R Schofield
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

5.  Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia.

Authors:  Maria-Jesús Sobrido; Bruce L Miller; Necat Havlioglu; Victoria Zhukareva; Zhihong Jiang; Ziad S Nasreddine; Virginia M-Y Lee; Tiffany W Chow; Kirk C Wilhelmsen; Jeffrey L Cummings; Jane Y Wu; Daniel H Geschwind
Journal:  Arch Neurol       Date:  2003-05

6.  Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation.

Authors:  Surendra S Ambegaokar; George R Jackson
Journal:  Hum Mol Genet       Date:  2011-09-23       Impact factor: 6.150

7.  Variation at APOE and STH loci and Alzheimer's disease.

Authors:  Lingjun Zuo; Christopher H van Dyck; Xingguang Luo; Henry R Kranzler; Bao-zhu Yang; Joel Gelernter
Journal:  Behav Brain Funct       Date:  2006-04-07       Impact factor: 3.759

Review 8.  Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Authors:  Cheng-Cheng Zhang; Jun-Xia Zhu; Yu Wan; Lin Tan; Hui-Fu Wang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2017-07-04

9.  Prioritization of candidate disease genes by topological similarity between disease and protein diffusion profiles.

Authors:  Jie Zhu; Yufang Qin; Taigang Liu; Jun Wang; Xiaoqi Zheng
Journal:  BMC Bioinformatics       Date:  2013-04-10       Impact factor: 3.169

Review 10.  Tau protein in familial and sporadic diseases.

Authors:  Despina Yancopoulou; Maria Grazia Spillantini
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.